Skip to main content

Table 2 Patient characteristics on admission with detail of the diagnostic categories

From: Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients

Variable

All

Complex cardiac surgery

Trauma

Subarachnoid hemorrhage

Number

200

113

66

21

 

AOX

Placebo

AOX

Placebo

AOX

Placebo

AOX

Placebo

Number

102

98

57

56

34

32

11

10

Gender, male/female

127/73

70/43a

52/14a

5/16a

Age, years

59 ± 19

70 ± 10a

40 ± 19a

54 ± 9

 

58 ± 19

59 ± 20

69 ± 8

71 ± 11

40 ± 19

40 ± 19

54 ± 7

53 ± 10

Weight, kg

74 ± 15

75 ± 16

75 ± 13

68 ± 12

 

74 ± 15

74 ± 15

75 ± 16

74 ± 17

72 ± 12

77 ± 13b

72 ± 13

64 ± 9c

Body mass index, kg/m2

25.8 ± 4.6

26.5 ± 5.0

24.9 ± 3.9

24.5 ± 3.4

 

25.8 ± 4.8

25.7 ± 4.3

26.7 ± 5.3

26.2 ± 4.7

24.2 ± 3.8

25.6 ± 3.9

25.2 ± 4.0

23.7 ± 2.5

SAPS II

37.5 ± 12.7

39.3 ± 10.4d

35.7 ± 15.4d

33.9 ± 13.6d

 

38.4 ± 12.7

36.6 ± 12.8

38.4 ± 9.3

40.3 ± 11.4

39.9 ± 17.0

31.1 ± 12.2e

33.6 ± 12.0

34.2 ± 9

SOFA score at admission

8.3 ± 2.5

9.1 ± 1.7a

7.5 ± 3.1a

6.3 ± 2.9a

 

8.2 ± 2.8

8.3 ± 2.2

8.8 ± 1.7

9.3 ± 1.6

7.8 ± 3.5

7.1 ± 3.2

5.7 ± 3.8

6.9 ± 1.4

  1. aP < 0.0001; bP = 0.08; cP = 0.14; dP = 0.07; eP = 0.01. Superscripts a and d refer to comparison between diagnostic categories. Superscripts b, c, and e refer to comparison between AOX and placebo (= P) groups. SAPS, Simplified Acute Physiology Score; SOFA, sequential organ failure assessment.